Scale -


  • Ebitda is 491 Rs Cr; Annual Growth is 16 %; Continuous Growth over 3 years; 5 Year CAGR is 18 %
  • Revenue is 2545 Rs Cr; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 16 %
  • PBT is 24.1 Rs Cr; Continuous Growth over 3 years; Annual Decline is -55 %; 5 Year CAGR is -27 %
  • Quarterly Revenue is 695 Rs Cr; Continuous Growth over 3 Quarters; in Top Quartile
  • Quarterly Profit is 15.53 Rs Cr; Continuous Growth over 3 Quarters
  • PAT is 21.31 Rs Cr; Annual Decline is -56 %; 5 Year CAGR is -15 %

Profitability -


  • PBDIT Margin is 19.28 %; Continuous Growth over 3 years
  • Quarterly Profit margin is 2 %; Continuous Growth over 3 Quarters; in Bottom Quartile
  • PAT Margin is 0.83 %; Annual Decline is -62 %; in Bottom Quartile; 5 Year CAGR is -27 %

Return -


  • ROA is 0.35 %; Annual Decline is -72 %; Continuous Decline over 3 years; in Bottom Quartile; 5 Year CAGR is -38 %
  • ROE is 1.03 %; Annual Decline is -79 %; Continuous Decline over 3 years; in Bottom Quartile; 5 Year CAGR is -36 %
  • Asset Turnover is 68 %; Continuous Decline over 3 years

Efficiency -


  • Current Ratio is 1.12; Annual Growth is 38 %; in Bottom Quartile
  • Quick Ratio is 1.06; Annual Growth is 39 %
  • Operating cash flow is 347 Rs Cr; Continuous Growth over 3 years

Solvancy -


  • Debt/Equity is 0.68; Annual Decline is -38 %; in Top Quartile
  • Contingent Liabilities is 264 Rs Cr; Continuous Decline over 3 years; in Top Quartile; 5 Year CAGR is 32 %
  • Long term Debt is 599 Rs Cr; in Top Quartile
  • Total Debt is 910 Rs Cr; in Top Quartile; 5 Year CAGR is 22 %

Quality -


  • Operating cashflow/PAT is 16.29 %; Annual Growth is 147 %; in Top Quartile; 5 Year CAGR is 31 %
  • Exceptional Items/PBT is -175 %; Continuous Decline over 3 years; in Bottom Quartile
  • Other Expenses/Total Expenses is 40 %; Continuous Decline over 3 years
  • Current Tax/PAT is 93 %; Annual Growth is 55 %; in Top Quartile
  • Operating cashflow/ebitda is 71 %; Continuous Decline over 3 years

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem


Sector
Major Subsidiaries/Associates
Key Clients

Products


Products
Product details

Operations


Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
HCG Trades Flat Near ?550 as Healthcare Global Enterprises Consolidates Within a Defined Range
Healthcare Global Indore Appoints Vikram Jha as the Chief Operating Officer
HealthCare Global Enterprises Ltd. Estimates – NSE:HCG
8 small, midcap stocks with upside potential of up to 50%. How many are in your portfolio?
12K breast cancer surgeries at HCG in Vijayawada
Hospitals to make their case to government as pricing scrutiny intensifies, says HCG
HealthCare Global Subsidiary Increases Stake in Kenya's AMIL to 50.10%; Makes it Step-Down Subsidiary